Cancer Research UK main site
Cancer Chat | Cancer Research UK
Cancer Chat | Cancer Research UK
  • Join
  • Sign in
  • Search forum
  • Join
  • Sign in
  • Home
  • Categories
  • Forum Help
  • More
  • Cancel
Squire

Squire

  • Profile
  • Activity
  • Friends
  • Mentions
  • More
  • Cancel
  • More
  • Cancel

About Squire

Diagnosed mid-Sept 2019 with Stage 4 oesophageal cancer - mets in liver at diagnosis. Incurable, but currently undergoing chemo to manage the condition. First scan post treatment (4 cycles of Oxaliplatin and Capecitabine) showed greater than 50% reduction in Liver mets with two disappearing altogether . Primary tumour has more modest reduction as did 2 Lymph modes, no new lesions. Very pleasing result!! Also had confirmation primary is HER2+ so am now going to be getting Herceptin - it often helps with the unknown factor being how long it continues helping. Time will tell Mar 5th - 8th and final chemo cycle. Herceptin only after this. Scan in two weeks to see how things are. It will be good to lose the side effects although slightly anxious about what will happen next.

Speak to a nurse

  • Nurse Helpline
    0808 800 4040
  • Questions about cancer? Call freephone
    9 to 5 Monday to Friday or email us

Quick links

  • Find local shops
  • Shop online
  • Contact us
  • Jobs

Follow us

  • Like Cancer Research UK on Facebook
  • Follow Cancer Research UK on Twitter
  • Follow Cancer Research UK on Instagram
  • Connect with Cancer Research UK on LinkedIn
  • Subscribe to Cancer Research UK on YouTube
  • About our information
  • Terms and conditions
  • Privacy
  • Modern Slavery Statement
  • Cookies
  • Accessibility
  • Sitemap
Registered with Fundraising Regulator (logo)
Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.